Evaluation of the six-minute walk test in patients with chronic heart failure associated with Chagas' disease and systemic arterial hypertension;Avaliação do teste de caminhada de seis minutos em pacientes com insuficiência cardíaca crônica associada à doença de Chagas e hipertensão arterial sistêmica

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 43, Issue 4, 2010, Pages 405-408

  Dourado, Kelly Cristina Colaço ^a   Bestetti, Reinaldo Bulgarelli ^a   Cardinalli Neto, Augusto ^a   Cordeiro, José Antônio ^a  

^a HOSPITAL DE BASE   (Brazil)

Author keywords

American Trypanosomiasis; Chagas disease; Functional capacity; Heart failure; Physical capacity; Six minute walk test

Indexed keywords

HEMOGLOBIN; POTASSIUM; SODIUM;

ADULT; ARTICLE; CHAGAS DISEASE; DISEASE ASSOCIATION; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHYSICAL CAPACITY; PHYSICAL PARAMETERS; POTASSIUM BLOOD LEVEL; QUESTIONNAIRE; SCORING SYSTEM; SODIUM BLOOD LEVEL; WALKING; WALKING TEST;

EID: 77957977453     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822010000400014     Document Type: Article

References (22)

1. Anonymous. A human rights-based approach to neglected tropical diseases. http://apps.who.int/tdr/svc/publication/tdr.researchpublications/humanri ghts. Accessed on August 20; 2009.
2. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007; 102(suppl):75-85.
3. Laranja FS, Dias E, Miranda A, Nóbrega G. Chagas' disease. A clinical, epidemiologic, and pathologic study. Circulation 1956; 14:35-60.
4. Rassi-Jr A, Rassi AG, Rassi SG, Rassi-Jr L, Rassi A. Ventricular arrhythmias in Chagas' disease. Diagnostic, prognostic, and therapeutic peculiarities. Arq Bras Cardiol 1995; 65:377-387.
5. Bestetti RB, Santos CRF, Machado-Jr OB, Ariolli MT, Carmo JL, Costa NK, et al. Clinical profile of patients with Chagas' disease before and during ventricular tachycardia. Int J Cardiol 1990; 29:39-46.
6. Bestetti RB. Stroke in a hospital-derived cohort of patients with chronic Chagas' disease. Acta Cardiol 2000; 55:33-38.
7. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas' disease. Stroke 2005; 36:965-970.
8. Bestetti RB, Ariolli MT, Carmo JL, Santos CRF, Machado-Jr O, Costa NK, et al. Clinical characteristics of acute myocardial infarction in patients with Chagas' Disease. Int J Cardiol 1992; 35:371-376.
9. Bestetti RB, Cardinalli-Neto A. Sudden cardiac death in Chagas' disease in the contemporary era. Int J Cardiol 2008; 131:9-17.
10. Bestetti RB, Theodoropoulos TAD, Cardinalli-Neto A, Cury PM. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy. Am Heart J 2008; 156:422-430.
11. Freitas OC, Carvalho FR, Neves JM, Veludo PK, Parreira RS, Gonçalves RM, et al. Prevalence of systemic arterial hypertension in the urban population of Catanduva city, São Paulo state, Brazil. Arq Bras Cardiol 2001; 77:9-15.
12. Gurgel CBFM, Miguel-Jr A, Mendes CR, Zerbini CO, Carcioni TM. Frequency of arterial hypertension in chronic Chagas' disease. A retrospective study. Arq Bras Cardiol 2003; 81:541-544.
13. Rossi MA, Ramos SG, Bestetti RB. Chagas' heart disease: clinical-pathological correlation. Front Biosci 2003; 8:e94-109.
14. Bestetti RB, Ramos CP, Figueredo-Silva J, Sales-Neto VN, Oliveira JSM. Ability of the electrocardiogram to detect myocardial lesions in isoproterenol-induced rat cardiomyopathy. Cardiovasc Res 1987; 21:916-921.
15. Bestetti RB. Role of parasites in the pathogenesis of Chagas' cardiomyopathy. Lancet 1996; 347:913-914.
16. Rector T, Cohn J. Assessment of patient outcome with the Minnesota Living With Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled clinical trial of pimobendan. Am Heart J 1992; 124:1017-1025.
17. Dourado KCC, Bestetti RB, Cordeiro JA, Theodoropoulos TAD. Assessment of quality of life in patients with chronic heart failure secondary to Chagas' cardiomyopathy. Int J Cardiol 2006; 108:412-413.
18. Souza L, Botoni FA, Britto RR, Rocha MOC, Teixeira-Jr AL, Teixeira MM, et al. Six-minute walk test in Chagas' cardiomyopathy. Int J Cardiol 2008; 125:139-141.
19. Miziara AN, Molina RJ, Ferreira BDC, Barbosa CJDG, Silva VJD, Prata A, et al. Cardiac autonomic modulation in hypertensive patients with Chagas' disease. Acta Tropica 2006; 97:188-195.
20. Gurgel CBFM, Almeida EA. Frequency of hypertension in patients with chronic Chagas' disease and its consequences on the heart: a clinical and pathological study. Arq Bras Cardiol 2007; 89:174-182.
21. Bertanha L, Guariento ME, Magna LA, Almeida EA. Clinical and laboratory characterization of hypertensive Chagas' disease patients without evident heart failure. Rev Soc Bras Med Trop 2008; 41:163-168.
22. Cahalin LP, Mathier MA, Semigran MJ, Dec W, Di Salvo TG. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996; 110:325-332.